Clinical Trial Update: Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating endoscopic ethanol ablation for communicating pancreatic cystic neoplasms was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucinous Cystic Neoplasm
• Pancreatic Cystic Neoplasms
• Pancreatic Neoplasms
• Serous Cystadenoma

Snippet

Sponsor: Mayo Clinic | Conditions: Neoplasms, Cystic, Mucinous, and Serous, Pancreatic Neoplasms | Phase 1 | Status: WITHDRAWN